Villanueva C - Search Results

1

Anticancer therapy in patients with porphyrias: evidence today.

Thiery-Vuillemin A, Chaigneau L, Meaux-Ruault N, Villanueva C, N'guyen T, Maurina T, Stein U, Lorgis V, Demarchi M, Pivot X. Thiery-Vuillemin A, et al. Among authors: villanueva c. Expert Opin Drug Saf. 2008 Mar;7(2):159-65. doi: 10.1517/14740338.7.2.159. Expert Opin Drug Saf. 2008. PMID: 18324878

2

Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up.

ESMO Guidelines Working Group; Pivot X, Villanueva C. ESMO Guidelines Working Group, et al. Among authors: villanueva c. Ann Oncol. 2007 Apr;18 Suppl 2:ii65-6. doi: 10.1093/annonc/mdm042. Ann Oncol. 2007. PMID: 17491053 Free article. No abstract available.

3

[Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue].

Villanueva C, Dufresne A, Pivot X, Viel E. Villanueva C, et al. Bull Cancer. 2008 Feb;95(2):197-204. doi: 10.1684/bdc.2008.0577. Bull Cancer. 2008. PMID: 18304905 Review. French.

4

Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence study.

Chaigneau L, Royer B, Montange D, Nguyen T, Maurina T, Villanueva C, Demarchi M, Borg C, Fagnoni-Legat C, Kantelip JP, Pivot X. Chaigneau L, et al. Among authors: villanueva c. Ann Oncol. 2008 Nov;19(11):1980-1. doi: 10.1093/annonc/mdn662. Ann Oncol. 2008. PMID: 18952760 Free article. Clinical Trial. No abstract available.

5

Ixabepilone: a new active chemotherapy in the treatment of breast cancer.

Villanueva C, Vuillemin AT, Demarchi M, Bazan F, Chaigneau L, Pivot X. Villanueva C, et al. Womens Health (Lond). 2009 Mar;5(2):115-21. doi: 10.2217/17455057.5.2.115. Womens Health (Lond). 2009. PMID: 19245349 Free article. Review.

6

Response rates: a valuable signal of promising activity?

Pivot X, Thierry-Vuillemin A, Villanueva C, Bazan F. Pivot X, et al. Among authors: villanueva c. Cancer J. 2009 Sep-Oct;15(5):361-5. doi: 10.1097/PPO.0b013e3181bd045f. Cancer J. 2009. PMID: 19826354 Review.

7

Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer.

Royer B, Yin W, Pegram M, Ibrahim N, Villanueva C, Mir D, Erlandsson F, Pivot X. Royer B, et al. Among authors: villanueva c. Br J Cancer. 2010 Mar 2;102(5):827-32. doi: 10.1038/sj.bjc.6605560. Epub 2010 Feb 16. Br J Cancer. 2010. PMID: 20160731 Free PMC article.

8

Safety profile of new anticancer drugs.

Mansi L, Thiery-Vuillemin A, Nguyen T, Bazan F, Calcagno F, Rocquain J, Demarchi M, Villanueva C, Maurina T, Pivot X. Mansi L, et al. Among authors: villanueva c. Expert Opin Drug Saf. 2010 Mar;9(2):301-17. doi: 10.1517/14740330903530663. Expert Opin Drug Saf. 2010. PMID: 20175699 Review.

9

Sequential taxane and anthracycline-containing neoadjuvant regimens: the sequential order impact.

Thiery-Vuillemin A, Llombart-Cussac A, Chaigneau L, Villanueva C, Bazan F, Montcuquet P, Maisonnette-Escot Y, Sautiere JL, Algros MP, Pivot X. Thiery-Vuillemin A, et al. Among authors: villanueva c. Breast. 2011 Feb;20(1):46-9. doi: 10.1016/j.breast.2010.07.001. Epub 2010 Aug 7. Breast. 2011. PMID: 20692157 Free article.

10

Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing medication errors.

Nerich V, Limat S, Demarchi M, Borg C, Rohrlich PS, Deconinck E, Westeel V, Villanueva C, Woronoff-Lemsi MC, Pivot X. Nerich V, et al. Among authors: villanueva c. Int J Med Inform. 2010 Oct;79(10):699-706. doi: 10.1016/j.ijmedinf.2010.07.003. Int J Med Inform. 2010. PMID: 20829102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

698 results

Search Page

Filters